外媒报道,私募股权公司KKR(KKR.US) 即将就收购瑞典消费者健康企业Karo Healthcare达成协议,后者估值超过25亿欧元(27亿美元)。
据网站介绍,Karo Healthcare拥有E45皮肤病学品牌,亦销售治疗咳嗽和感冒的产品以及维生素产品。(sw/m)(美股为即时串流报价; OTC市场股票除外,资料延迟最少15分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.